AC Immune (ACIU) Divestments (2016 - 2025)
AC Immune (ACIU) reported Divestments of $186.3 million for Q3 2025, up 212.21% year-over-year from $59.7 million in Q3 2024, and up 529.85% on a QoQ basis from $29.6 million in Q1 2025.
AC Immune (ACIU) has 10 years of Divestments data on file, last reported at $186.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 186.27 Mn |
| Mar 31, 2025 | 29.57 Mn |
| Sep 30, 2024 | -166.01 Mn |
| Jun 30, 2024 | -125.46 Mn |
| Mar 31, 2024 | -26.99 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | -5.73 Mn |
| Mar 31, 2023 | 46.27 Mn |
| Sep 30, 2022 | -5.30 Mn |
| Jun 30, 2022 | 25.40 Mn |
| Mar 31, 2022 | -584,716.52 |
| Sep 30, 2021 | -26.86 Mn |
| Jun 30, 2021 | -33.62 Mn |
| Mar 31, 2021 | -873,786.66 |
| Sep 30, 2020 | 16.02 Mn |
| Jun 30, 2020 | 9.99 Mn |
| Mar 31, 2020 | -219,175.48 |
| Sep 30, 2019 | -10.61 Mn |
| Jun 30, 2019 | -338,087.38 |
| Mar 31, 2019 | -50.72 Mn |
| Mar 31, 2018 | -1.22 Mn |
| Sep 30, 2017 | -281,650.54 |
| Jun 30, 2017 | -936,843.80 |
| Mar 31, 2017 | -638,412.59 |
| Sep 30, 2016 | -313,686.90 |
| Jun 30, 2016 | -99,971.90 |
| Mar 31, 2016 | -211,452.72 |